Valuation China Shineway Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 12:08:08 30/10/2026 +04			5-day change	1st Jan Change
7.505 ^HKD	+3.09%		+3.95%	-12.73%

09-29	China Shineway Pharmaceutical Group Limited Announces Board and Committee Changes, Effective 1 October 2026	CI
09-18	China Shineway Pharmaceutical Group Limited Declares Special Interim Dividend in Respect of the Fiscal Year Ending 31 December 2026, Payable on 15 October 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,240	5,072	4,985	6,850	5,838	4,810	-	-
Change	-	19.61%	-1.71%	37.41%	-14.78%	-17.61%	-	-
Enterprise Value (EV)	49.32	25.13	4,985	6,850	5,838	4,810	4,810	4,810
Change	-	-49.04%	19,734.74%	37.41%	-14.78%	-17.61%	0%	0%
P/E	7.59x	6.99x	5.16x	8.17x	6.13x	6.37x	5.93x	5.57x
PBR	0.72x	0.79x	0.71x	-	0.72x	0.61x	-	-
PEG	-	0.2x	0.2x	-0.6x	0.5x	-0.3x	0.8x	0.87x
Capitalization / Revenue	1.32x	1.28x	1.1x	1.81x	1.86x	2.05x	2.05x	1.98x
EV / Revenue	0x	0x	0x	0x	0x	2.05x	2.05x	1.98x
EV / EBITDA	0x	0x	0x	0x	0x	5.92x	5.56x	5.28x
EV / EBIT	0x	0x	0x	0x	0x	5.92x	5.56x	5.28x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	0.39	0.32	0.42	0.54	-	-	-	-
Rate of return	6.95%	4.77%	6.36%	5.95%	-	-	-	-
EPS ²	0.74	0.96	1.28	1.11	1.26	1	1.074	1.143
Distribution rate	52.7%	33.3%	32.8%	48.6%	-	-	-	-
Net sales ¹	3,224	3,951	4,517	3,778	3,135	2,344	2,347	2,427
EBITDA ¹	826	1,022	1,316	1,306	1,047	813	865	911
EBIT ¹	643.6	835.8	1,139	1,025	896	813	865	911
Net income ¹	556.7	722.8	969.5	840.1	949.9	755	811	864
Net Debt	-4,191	-5,046	-	-	-	-	-	-
Reference price ²	5.613	6.714	6.599	9.068	7.728	6.367	6.367	6.367
Nbr of stocks (in thousands)	755,400	755,400	755,400	755,400	755,400	755,400	-	-
Announcement Date	29/03/22	30/03/23	28/03/24	28/03/25	27/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED	6.18x	-	-	-	701M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	28.05x	7.29x	19.41x	2.05%	417.75B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%